RCM
TARA icon

RA Capital Management’s Protara Therapeutics TARA Stock Holding History

RA Capital Management’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,039,295
Closed -$3.15M – 72
2025
Q2 		$3.15M Sell
1,039,295
-2,360,705
-69% -$8.14M 0.05% 60
2025
Q1 		$14.5M Hold
3,400,000
– – 0.24% 58
2024
Q4 		$18M Buy
3,400,000
+1,500,000
+79% +$4.85M 0.24% 60
2024
Q3 		$3.48M Hold
1,900,000
– – 0.04% 74
2024
Q2 		$3.95M Buy
+1,900,000
New +$5.56M 0.05% 74
2019
Q1 		– Sell
-33,437
Closed -$3.04M – 30
2018
Q4 		$3.04M Hold
33,437
– – 0.18% 25
2018
Q3 		$2.61M Hold
33,437
– – 0.14% 26
2018
Q2 		$3.28M Hold
33,437
– – 0.21% 26
2018
Q1 		$3.34M Hold
33,437
– – 0.26% 28
2017
Q4 		$2.54M Hold
33,437
– – 0.21% 25
2017
Q3 		$2.67M Hold
33,437
– – 0.24% 27
2017
Q2 		$2.04M Buy
+33,437
New +$1.87M 0.23% 22
2016
Q4 		– Sell
-40,673
Closed -$15.2M – 34
2016
Q3 		$15.2M Hold
40,673
– – 1.57% 15
2016
Q2 		$13.1M Hold
40,673
– – 1.81% 14
2016
Q1 		$12.6M Buy
40,673
+3,750
+10% +$1.21M 1.61% 20
2015
Q4 		$22.9M Sell
36,923
-749
-2% -$439K 2.27% 15
2015
Q3 		$21M Hold
37,672
– – 3.01% 11
2015
Q2 		$26.9M Buy
37,672
+6,422
+21% +$3.97M 2.71% 13
2015
Q1 		$14.5M Hold
31,250
– – 1.44% 20
2014
Q4 		$13M Buy
+31,250
New +$12.6M 1.4% 22

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RA Capital Management's TARA Position: Q3 2025 in Review

RA Capital Management sold out of Protara Therapeutics (TARA) in Q3 2025, closing a stake of 1,039,295 shares — an estimated $3.15M sold.

RA Capital Management first reported a position in TARA in Q4 2014 and held it in 20 quarters. The position peaked at $26.9M in Q2 2015. 81 funds tracked by Wall St. Rank hold TARA as of Q3 2025.

  • RA Capital Management reported no remaining Protara Therapeutics position as of Q3 2025 after selling out during the quarter.
  • RA Capital Management sold 1,039,295 Protara Therapeutics shares in Q3 2025, an estimated $3.15M.
  • RA Capital Management first reported a position in Protara Therapeutics in Q4 2014 and held it in 20 quarters.
  • RA Capital Management's Protara Therapeutics position peaked at $26.9M in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2025.

Based on RA Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.